TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05641480

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation&Music therapy
Description: Procedure: electro-acupuncture;Points: Shenting（DU24）, Benshen（BG13）, Tou Wei （ST8）.The specially-made pad is stick on pierced acupoints, until local sour and heavy feeling coming. The electric stimulator is applied to bilateral BG13 and ST8, with dilatational wave,10/50 Hz and electric current 1-5mA(milliampere).Every session lasts for 30 min per day. The participants are treated continuously for 8 weeks for 3 sessions a week, 24 sessions for each participants in all.~Selecting the participants' music of memory and music of favourite(Music is purchased and downloaded from music stores), forming a personalized music playlist, and the decibel level is suitable for participants.~The treatment is designed based on recent literature research in 10 years, former result and expert consensus.~Other Names:~* JS-502-A Intelligent and portable electroacupuncture~* apparatus(Han's low frequency neuromodulator, made in China)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation&Music therapy
Description: Procedure: electro-acupuncture;Points: Shenting（DU24）, Benshen（BG13）, Tou Wei （ST8）.The specially-made pad is stick on pierced acupoints, until local sour and heavy feeling coming. The electric stimulator is applied to bilateral BG13 and ST8, with dilatational wave,10/50 Hz and electric current 1-5mA(milliampere).Every session lasts for 30 min per day. The participants are treated continuously for 8 weeks for 3 sessions a week, 24 sessions for each participants in all.~Selecting the participants' music of memory and music of favourite(Music is purchased and downloaded from music stores), forming a personalized music playlist, and the decibel level is suitable for participants.~The treatment is designed based on recent literature research in 10 years, former result and expert consensus.~Other Names:~* JS-502-A Intelligent and portable electroacupuncture~* apparatus(Han's low frequency neuromodulator, made in China)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil hydrochloride tablets or carpalatine bitartrate tablets
Description: ① Donepezil hydrochloride tablets 5 mg, once a day, one tablet each time, before going to bed. The treatment period is 6 months.~② Carpalatine heavy tartrate tablets 1.5mg, 1 tablet/time 2 weeks before treatment, twice a day, breakfast and dinner with food, swallow. If there is no obvious adverse reaction after 2 weeks, the dosage can be increased to 2 tablets/time, twice a day. The treatment period is 6 months.
Study: NCT05402488

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Auditory stimulation
Description: Auditory stimulation during sleep

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Auditory stimulation
Description: Auditory stimulation during sleep
Study: NCT04988581

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensively integrated care of microvascular risk factors in the intervention group
Description: The intensively integrated care, which will provide a standardized, combined, multi-component intervention according to clinical guideline treatment for diabetes and comorbidities in a primary care setting, will be delivered by trained primary care physicians, health managers and diabetes specialists. Diabetic microvascular risk factors (glycated hemoglobin \[HbA1C\], urinary albumin-to-creatinine ratio \[ACR\], blood pressure \[BP\], estimated glomerular filtration rate \[eGFR\], uric acid \[UA\] and low-density lipoprotein cholesterol \[LDL\]) will be tested every 3 month for the intervention group and clinical treatment decisions based on the test results will be implemented accordingly when necessary. The intensively integrated care intervention will last for 36 months. HbA1C, ACR, BP, eGFR, UA, LDL, other variables and co-morbidities will be measured at baseline and follow-up visits every 3 month.
Study: NCT06456502

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive neuromodulation
Description: The treatment plan of non- invasive neuromodulation will be applied for two months, with a frequency of 2 weekly sessions of one hour duration, until completing a total of 15 sessions for each patient. The sessions will always be applied in the same time slot of the day (to avoid influence on the measurements, specially cortisol).

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The treatment plan of placebo will be applied for two months, with a frequency of 2 weekly sessions of one hour duration, until completing a total of 15 sessions for each patient. Participants will be attached to the neuromodulation machine, however, the cable will not be connected. Participants will not be able to see the machine connections. The sessions will always be applied in the same time slot of the day (to avoid influence on the measurements, specially cortisol).
Study: NCT05240391

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midodrine Hydrochloride
Description: Midodrine hydrochloride for PICD prevention

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human Albumin 20%
Description: Human ALbumin 20% for prevention of paracentesis induced circulatory disturbance
Study: NCT06395337

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [111In]In-DOTA-ANTI-CEA antibody injection
Description: tracer injection

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SPECT/CT scan
Description: abdominal and thoracic SPECT/CT scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resection surgery
Description: oncological resection surgery will be performed extended with the use of dual-modality imaging.
Study: NCT06393699

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NCCL restoration using resin composite materials
Description: different types of resin composite restorations will be used to restore NCCL

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NCCL restoration using resin composite materials
Description: different types of resin composite restorations will be used to restore NCCL

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NCCL restoration using resin composite materials
Description: different types of resin composite restorations will be used to restore NCCL

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NCCL restoration using resin composite materials
Description: different types of resin composite restorations will be used to restore NCCL
Study: NCT06492746

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring
Description: The arterial line with Acumen IQ sensor and Foresight Elite sensor will be connected to the HemoSphere monitor with laptop displaying the CAI parameter.
Study: NCT05626868

Intervention type: DEVICE
Intervention: Intra abdominal pressure measurement
Description: Device: Biometrix - Intraabdominal pressure monitoring set Intraabdominal pressure monitoring with the intended set in values of milimeters of mercury (mmHg) in real time.
Study: NCT06271746

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FibroNova (Active mode)
Description: FibroNova neurostimulator of conditional pain modulation (CPM)

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: FibroNova (Sham mode)
Description: FibroNova neurostimulator with an electrical output not intended for neurostimulation
Study: NCT04766840

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAR-T cells
Description: Drug: IM73 CAR-T Cells Drug: Fludarabine Two days before cell infusion, patient will be treated with fludarabine for 3 days Drug: Cyclophosphamide: Two days before cell infusion, patient will be treated with Cyclophosphamide for 3 days
Study: NCT04591353

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PENG Block
Description: The pericapsular nerve group (PENG) block is a novel regional anesthesia technique for providing analgesia after hip fractures and hip arthroplasties.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: 2-3 cc of 2% lidocaine and NO bolus of bupivacaine will be injected.
Study: NCT05459896

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Training
Description: Participants who exhibit both physical and psychosocial distress will be recommended to receive physical activity intervention. An approach of adding game mechanics into an interactive environment that combines live action and an award system will be integrated into the intervention. The physical training involves 15-min resistance training and 30-min interactive cardio dancing each with beginner and advanced levels. Participants are recommended to start with the beginner level and do the exercises on regular intervals during the intervention period. The Light Detection and Ranging (LiDAR) motion sensor with tablet-based console and the full-body tracking sensor will be used to capture real-time data on participants' human body movements in order to enhance understanding of performance. Participants will get a commercial wearable sensor. Participants will be asked to wear the sensor at all times and sync the data with the Smart Health Platform to self-monitor daily condition.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Intervention
Description: Participants who exhibit psychosocial distress will be recommended to receive mindfulness-based intervention which is designed based on the concept of validated Mindfulness-Based Stress Reduction (MBSR) combined with techniques from Mindfulness-Based Cognitive Therapy (MBCT). The intervention consists of 10 sessions, each session has different main themes and associated activities including body scan, mindful eating, abdominal breathing, chair yoga, awareness of breathing, mindful walking, breathing, body and emotions, yoga stretching, mindful listening and choiceless awreness. The materials will be delivered in the format of animation videos. Participants will be asked to complete one session per week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Energy Conservation Techniques
Description: Participants who exhibit physiological symptoms will be recommended to receive energy savings intervention which is co-developed by the local Occupational Therapy Association. The intervention consists of six session, each session has different topics and associated energy savings techniques related to particular circumstances, such as the six principle of energy conservation, application of energy conservation in the domains of self-care, household tasks, outdoor activities and work. The materials will be delivered in the format of animation videos. Participants will be asked to complete one session per week. Revision quiz will be given to understand the learning progress of participants.
Study: NCT04986267

Intervention type: OTHER
Intervention: ACL Rupture
Description: Female, aged 18-40 years of age with an acute ACL rupture of the knee that occurred within the last 3 months, who presented to a sports or orthopaedic clinic
Study: NCT06289907

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Bonafide-HF3.0
Description: Take 2 capsules once daily in the mornings with food

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Take 2 capsules once daily in the mornings with food
Study: NCT05542030

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: EMR with CAD-Eye™
Description: Patients of group 1 undergoing Intervention 1 are subjected to an EMR with CAD-Eye™ to detect the remaining lesions immediately after the endoscopic procedure.~The suspected remaining lesions in the post-procedure defect detected with CAD-Eye™ are removed and sent to pathology to confirm the diagnosis.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: EMR without CAD-Eye™
Description: Patients of group 2, undergoing intervention 2, subjected to an EMR alone. The immediate detection of remaining lesions is based on the visual impression of the expert.~The suspected remaining lesions in the post-procedure defect are removed and sent to pathology to confirm the diagnosis.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Follow-up colonoscopy with CAD-Eye™
Description: Patients undergoing Interventions 1 and 2, with a previous EMR, are assigned for a three-month follow-up using the CAD-Eye™ as a complementary procedure to detect remaining lesions.~For the detection of residual lesions, the colonoscope with the CAD-Eye™ assistance is used during the post-procedural scar evaluation. Suspicious lesions detected are removed and sent to pathology for final diagnosis.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Follow-up colonoscopy with CAD-Eye™
Description: Patients undergoing Interventions 1 and 2, with a previous EMR, are assigned for a three-month follow-up using the CAD-Eye™ as a complementary procedure to detect remaining lesions.~For the detection of residual lesions, the colonoscope with the CAD-Eye™ assistance is used during the post-procedural scar evaluation. Suspicious lesions detected are removed and sent to pathology for final diagnosis.
Study: NCT05046561

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: STRI Formula
Description: STRI Formula is a combination of food based substances (botanicals, vitamins, minerals, and protein) with multiple, distinct, synergistic, direct and indirect antiviral effects against SARS-CoV-2

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral capsule
Study: NCT04417699

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAS 102
Description: Oral medication over Days 1-5

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Administered by intravenous infusion over 2 hours on day 1
Study: NCT05684393

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: frequency distribution type
Description: One group is fitted using channel filterbank frequency distribution based on anatomy data extracted from post-OP CT measurements. The second (control) group is fitted with the standard frequency distribution used in MAESTRO 9 fitting software.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: frequency distribution type
Description: One group is fitted using channel filterbank frequency distribution based on anatomy data extracted from post-OP CT measurements. The second (control) group is fitted with the standard frequency distribution used in MAESTRO 9 fitting software.
Study: NCT05757544

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Ganaxolone
Description: IV Ganaxolone will be administered.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IV Ganaxolone
Description: IV Ganaxolone will be administered.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IV Placebo
Description: IV Placebo will be administered
Study: NCT05338814

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: scapular corrective exercises
Description: 40 minutes each, three times a week for six weeks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional neck exercises
Description: 40 minutes each, three times a week for six weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional neck exercises
Description: 40 minutes each, three times a week for six weeks
Study: NCT04808661

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thoracic endovascular aortic repair plus optimal medical therapy
Description: Endovascular treatment (thoracic endovascular aortic repair) plus optimal medical therapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Optimal medical therapy
Description: Optimal medical therapy (strictly control of their blood pressure and heart rate)
Study: NCT05190497

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exercise group
Description: Maximal respiratory pressure and reflecting muscles strength were measured by a mouth pressure meter
Study: NCT04989868

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trans-Nasal Afferent Loop Decompression
Description: A 14Fr silicon tube with multiple side holes within the range of 15 cm from the tip will be placed into the afferent jejunal limb with its end close to the pancreaticojejunostomy (\<3 cm) during the surgery. Continuous closed negative-pressure suction will be applied to that tube for 72 hours and after that the nasogastric tube will be removed. No nasogastric tube will be placed, or the nasogastric tube will be removed immediately after extubation.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Without Trans-Nasal Afferent Loop Decompression
Description: No decompression tube will be placed. No nasogastric tube will be placed, or the nasogastric tube will be removed immediately after extubation.
Study: NCT05408442

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT04441086

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eMotion
Description: Content is delivered within the context of emotion provoking situations common in those recovering from a first MI and in maintaining MVPA. The new on-demand access to asynchronous content sessions provides didactic presentation of video and written material based on weekly needs assessments. Weekly scheduled synchronous video chat sessions, led by a nurse interventionist, will provide further individualization and application of content materials.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Living Active Control
Description: The attention control group will receive their usual cardiac rehabilitation and a comparable dose matched (to that of the eMotion intervention) of healthy living web content and video chat with a nurse.
Study: NCT04946981

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Turmipure Gold®
Description: TPG: Turmipure GOLD® - 1 capsule per day - as prescribed

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Turmipure Gold®
Description: TPG: Turmipure GOLD® - 1 capsule per day - as prescribed

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Placebo
Description: Placebo: colored acacia gum - 1 capsule per day - as prescribed

Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Placebo
Description: Placebo: colored acacia gum - 1 capsule per day - as prescribed
Study: NCT04673019

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Nurse AMIE (Addressing Metastatic Individuals Every day)
Description: Supportive Care Platform (behavioral interventions that are offered based on answers to daily symptom rating questions). Interventions offered include walking, balance, strength exercise, guided relaxation, CBT, DBT, soothing music.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse AMIE (Addressing Metastatic Individuals Every day)
Description: Supportive Care Platform (behavioral interventions that are offered based on answers to daily symptom rating questions). Interventions offered include walking, balance, strength exercise, guided relaxation, CBT, DBT, soothing music.
Study: NCT05461508

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Amoxicillin combined with vonoprazan and fucoidan
Description: Fucoidan was used in combination with amoxicillin and vonoprazan. The purpose of this study was to explore the effect of fucoidan on the eradication rate of Helicobacter pylori and the intestinal flora of subjects.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin combined with vonoprazan
Description: Amoxicillin and vonoprazan were used as the study control group
Study: NCT04682054

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ocular surgery
Description: surgery to remove the pathological eye tissue
Study: NCT06473636

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Description: The mindfulness training program consisted of four 45-minute lessons, conducted once a week. After each lesson, participants were required to complete daily homework, which included the mindfulness exercises learned during that week for at least 30 minutes. The mindfulness training program was based on Kabat-Zinn's Mindfulness-Based Stress Reduction and Williams' Mindfulness-Based Cognitive Therapy. Additionally, specific contents of cancer-related mindfulness training were incorporated into this program, such as Anti-cancer Self-healing Power: 8 Lessons in Mindfulness-based Stress Reduction.
Study: NCT06374563

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: group 1 received topical Bee venom gel
Description: Group 1 received a topical application of Bee Venom gel, 3 times per weeks. The wound dressing changed day after day and was cleaned every time with normal saline.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group 2: Phonophoresis of Bee Venom gel
Description: group 2 received phonophoresis of Bee Venom gel using low frequency ultrasound, 3 times per weeks
Study: NCT06214273

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low level diode laser
Description: diode laser with a wave length range of 800-980 n m and power less than 500 ml

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chamomile
Description: Chamomile 3% mucoadhesive gel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen analgesic and anti-inflammatory oral gel and miconazole anti fungal oral gel
Description: Topical anti-inflammatory, topical analgesic and topical antifungal
Study: NCT05247047

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENA SmartCare Change Indicator
Description: The intervention is a medical device system that consists of a reusable electronic sensor and an application installed on one or more smart phones. The device estimates the saturation level of an absorbing incontinence product used by a study subject. The device is non-invasive and does not have any effect on the function of the absorbing incontinence product.
Study: NCT05824780

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise training
Description: 4-week weightlifting strength training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise training
Description: 4-week weightlifting strength training
Study: NCT04217304

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Definity® with High Mechanical Index Ultrasound
Description: Sonothrombolysis; Echocardiographic imaging with intermittent diagnostic high mechanical index during an intravenous 5% Definity® infusion
Study: NCT04639258

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Medtronic Evolut™ PRO+ System
Description: TAVR treatment with Medtronic Evolut™ PRO+ System
Study: NCT05302726

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Estrogen
Description: Transdermal and oral estrogen both as substitution therapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Estrogen
Description: Transdermal and oral estrogen both as substitution therapy